Truist Financial Reiterates “Buy” Rating for Silgan (NYSE:SLGN)

Truist Financial reissued their buy rating on shares of Silgan (NYSE:SLGN – Free Report) in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a $52.00 target price on the industrial products company’s stock. SLGN has been the topic of a number of other reports. Royal Bank of Canada decreased their price […]

Leave a Reply

Your email address will not be published.

Previous post Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Reiterated by Cantor Fitzgerald
Next post StockNews.com Begins Coverage on Team (NYSE:TISI)